T cell aging and Alzheimer's disease

Area of Science:

• Neuroimmunology
• Aging Research
• Alzheimer's Disease Pathogenesis

Background:

• The brain's immune privilege via the blood-brain barrier (BBB) is challenged by T cell roles in neuroinflammation.
• T cells, particularly through the meningeal lymphatic system, are increasingly recognized for their brain functions.
• Age is a significant risk factor for Alzheimer's disease (AD), correlating with age-related changes in T cell immunity.

Purpose of the Study:

• To review and integrate current knowledge on the interplay between T cells, aging, and Alzheimer's disease.
• To highlight the limitations of current AD therapies (e.g., amyloid beta targeting).
• To emphasize the need for understanding T cell aging in AD for novel therapeutic development.

Main Methods:

• Comprehensive literature review of studies on T cells and AD.
• Analysis of T cell aging mechanisms and their impact on brain immunity.
• Integration of findings on T cell involvement in non-lymphoid organ aging and AD.

Main Results:

• Age-dependent alterations in T cells significantly influence AD pathology.
• Peripheral T cell responses can modulate AD progression.
• T cell aging presents a critical, yet understudied, factor in AD pathogenesis.

Conclusions:

• A deeper understanding of T cell aging in AD is crucial for advancing therapeutic interventions.
• Targeting age-related T cell dysfunctions may offer new avenues for AD prevention and treatment.
• Future research should focus on the integrated role of T cells and aging in Alzheimer's disease.